Glucosa Y Cloruro Potásico Baxter (Potassium Chloride, Glucose)

Glucosa Y Cloruro Potásico Baxter is used in medical practice to address specific electrolyte and energy needs.

• Correction of hypokalemia when rapid potassium repletion is required.
• Provision of glucose to support metabolic energy in patients unable to intake orally.
• Management of electrolyte disturbances during surgery or intensive care.
• Treatment of patients with combined potassium and glucose deficits, such as in certain renal or gastrointestinal losses.
• Support for patients receiving parenteral nutrition who need potassium and carbohydrate supplementation.
• Use in emergency settings to quickly restore plasma potassium and provide immediate caloric source.

Potential adverse effects of Glucosa Y Cloruro Potásico Baxter are documented in clinical practice; while many patients tolerate the intravenous infusion without issue, healthcare providers monitor for both frequent mild reactions and less common serious complications that may arise during or after administration.

Common

• Mild vein irritation or pain at the injection site.
• Transient nausea or vomiting.
• Temporary increase in blood glucose levels.
• Mild headache or dizziness during infusion.
• Local swelling or erythema at the infusion site.

Serious

• Hyperkalemia leading to cardiac arrhythmias.
• Severe allergic reaction such as anaphylaxis.
• Rapid shifts in fluid balance causing pulmonary edema.
• Severe hyperglycemia in patients with impaired glucose tolerance.
• Cardiac arrest due to extreme hyperkalemia.

When prescribing Glucosa Y Cloruro Potásico Baxter, clinicians consider several precautionary measures to ensure safe administration and to minimize risk.

• Assess serum potassium and glucose levels before infusion.
• Use caution in patients with renal impairment or heart failure.
• Monitor cardiac rhythm and blood pressure during administration.
• Avoid rapid infusion rates to prevent hyperkalemia.
• Adjust dose in patients receiving other potassium-containing solutions.
• Observe for signs of allergic reaction throughout the infusion.
• Check for hyperglycemia in diabetic patients and adjust insulin therapy as needed.

Glucosa Y Cloruro Potásico Baxter may interact with other medications; awareness of these interactions helps prevent adverse outcomes.

Avoid

• Concurrent use of other potassium supplements or high-potassium diets that could cause hyperkalemia.
• Administration with rapid intravenous calcium solutions, which may precipitate.
• Co-administration with insulin without glucose monitoring, risking hypoglycemia.
• Simultaneous infusion with blood products containing potassium, which may increase potassium load.

Use with caution

• Loop diuretics, which increase potassium loss and may require dose adjustment.
• ACE inhibitors or ARBs, which can raise serum potassium levels.
• Beta‑blockers, which may mask signs of hypoglycemia.
• Sodium bicarbonate, which can shift potassium intracellularly.
• Renal replacement therapy patients, as altered clearance may affect potassium balance.